STAT News · Scour

STAT+: NIH grant awards are again lagging far behind historical averages, analysis shows

statnews.com·8w

Opinion: The greatest threat to federally qualified health centers may not be federal funding cuts

statnews.com·8w

Opinion: Semaglutide is going off-patent in India. But will people who need it be able to get it?

statnews.com·8w

STAT+: For decades, they’ve set the record straight in biology. Next up: science’s reproducibility crisis

statnews.com·8w

STAT+: White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception

statnews.com·8w

Federal judge stalls health secretary RFK Jr.’s overhaul of vaccine policy

statnews.com·8w·Hacker News

STAT+: Medicaid still going commercial

statnews.com·8w

STAT+: Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says

statnews.com·8w

STAT+: A brain-computer interface allowed people with paralysis to type with their mind

statnews.com·8w

STAT+: Two more drugmakers join TrumpRx

statnews.com·8w

STAT+: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more

statnews.com·8w

Disabled CDC staff still missing accommodations

statnews.com·8w

STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill

statnews.com·8w

Opinion: I have a genetic mutation linked to ALS. The Trump administration terrifies me

statnews.com·8w

Opinion: Congress must pass legislation to ensure Medicare covers breakthrough medical technologies

statnews.com·8w

STAT+: New technologies promise to transform organ transplantation. But when?

statnews.com·8w

How STAT would cover ‘The Fugitive’ if its pharma scandal were real

statnews.com·9w

Major changes to cardiovascular guidelines suggest taking statins as young as 30

statnews.com·9w·Hacker News

STAT+: Up and down the ladder: The latest comings and goings

statnews.com·9w

STAT+: Grail CEO steps down after trial setback

statnews.com·9w

Log in to enable infinite scrolling